Literature DB >> 15600239

Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.

Noer Kasanah1, Mark T Hamann.   

Abstract

Antibiotics remain essential tools in the control of infectious diseases. With the emergence of new diseases, resistant forms of diseases such as tuberculosis and malaria, as well as the emergence of multidrug-resistant bacteria, it has become essential to develop novel antibiotics. Development of the existing antibiotics involved three strategies, including discovery of new target sites, modification of existing antibiotic structures, and the identification of new resources for novel antibiotics. Marine microorganisms have clearly become an essential new resource in the discovery of new antibiotic leads.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15600239      PMCID: PMC4969015     

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  61 in total

1.  YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties.

Authors:  Koji Nagai; Kazuma Kamigiri; Nakako Arao; Ken-ichi Suzumura; Yasuhiro Kawano; Masakazu Yamaoka; Huiping Zhang; Masato Watanabe; Kenichi Suzuki
Journal:  J Antibiot (Tokyo)       Date:  2003-02       Impact factor: 2.649

Review 2.  Gone gene fishing: how to catch novel marine antimicrobials.

Authors:  Aleksander Patrzykat; Susan E Douglas
Journal:  Trends Biotechnol       Date:  2003-08       Impact factor: 19.536

3.  Engineering of primary carbon metabolism for improved antibiotic production in Streptomyces lividans.

Authors:  Michael J Butler; Per Bruheim; Srdjan Jovetic; Flavia Marinelli; Pieter W Postma; Mervyn J Bibb
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

Review 4.  Where will new antibiotics come from?

Authors:  Christopher Walsh
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

5.  Bioactive metabolites from a marine-derived strain of the fungus Emericella variecolor.

Authors:  Joan Malmstrøm; Carsten Christophersen; Alejandro F Barrero; J Enrique Oltra; José Justicia; Antonio Rosales
Journal:  J Nat Prod       Date:  2002-03       Impact factor: 4.050

6.  Applications of gene replacement technology to Streptomyces clavuligerus strain development for clavulanic acid production.

Authors:  A S Paradkar; R H Mosher; C Anders; A Griffin; J Griffin; C Hughes; P Greaves; B Barton; S E Jensen
Journal:  Appl Environ Microbiol       Date:  2001-05       Impact factor: 4.792

7.  Arisostatins A and B, new members of tetrocarcin class of antibiotics from Micromonospora sp. TP-A0316. I. Taxonomy, fermentation, isolation and biological properties.

Authors:  T Furumai; K Takagi; Y Igarashi; N Saito; T Oki
Journal:  J Antibiot (Tokyo)       Date:  2000-03       Impact factor: 2.649

8.  Metabolites from the Sponge-Associated Bacterium Pseudomonas Species.

Authors: 
Journal:  Mar Biotechnol (NY)       Date:  1999-07       Impact factor: 3.619

9.  YM-202204, a new antifungal antibiotic produced by marine fungus Phoma sp.

Authors:  Koji Nagai; Kazuma Kamigiri; Hisao Matsumoto; Yasuhiro Kawano; Masakazu Yamaoka; Hitoshi Shimoi; Masato Watanabe; Kenichi Suzuki
Journal:  J Antibiot (Tokyo)       Date:  2002-12       Impact factor: 2.649

10.  Chalcomycin B, a new macrolide antibiotic from the marine isolate Streptomyces sp. B7064.

Authors:  Ratnakar N Asolkar; Rajendra P Maskey; Elisabeth Helmke; Hartmut Laatsch
Journal:  J Antibiot (Tokyo)       Date:  2002-10       Impact factor: 2.649

View more
  6 in total

Review 1.  Antibacterials from the sea.

Authors:  Chambers C Hughes; William Fenical
Journal:  Chemistry       Date:  2010-11-08       Impact factor: 5.236

2.  An analysis of the sponge Acanthostrongylophora igens' microbiome yields an actinomycete that produces the natural product manzamine A.

Authors:  Amanda L Waters; Olivier Peraud; Noer Kasanah; James W Sims; Nuwan Kothalawala; Matthew A Anderson; Samuel H Abbas; Karumanchi V Rao; Vijay R Jupally; Michelle Kelly; Amala Dass; Russell T Hill; Mark T Hamann
Journal:  Front Mar Sci       Date:  2014-10-17

Review 3.  Novel Targets for Antimicrobials.

Authors:  Suchita Gupta; Vaishali Ravindra Undale; Kedar Lakhadive
Journal:  Turk J Pharm Sci       Date:  2020-10-30

Review 4.  Marine Microbial-Derived Antibiotics and Biosurfactants as Potential New Agents against Catheter-Associated Urinary Tract Infections.

Authors:  Shuai Zhang; Xinjin Liang; Geoffrey Michael Gadd; Qi Zhao
Journal:  Mar Drugs       Date:  2021-04-29       Impact factor: 5.118

5.  Ethyl 3-oxo-2-(2,5-dioxopyrrolidin-3-yl)butanoate Derivatives: Anthelmintic and Cytotoxic Potentials, Antimicrobial, and Docking Studies.

Authors:  Fawad Mahmood; Muhammad S Jan; Sajjad Ahmad; Umer Rashid; Muhammad Ayaz; Farhat Ullah; Fida Hussain; Ashfaq Ahmad; Arif-Ullah Khan; Muhammad Aasim; Abdul Sadiq
Journal:  Front Chem       Date:  2017-12-12       Impact factor: 5.221

6.  New marine-derived indolymethyl pyrazinoquinazoline alkaloids with promising antimicrobial profiles.

Authors:  Solida Long; Diana I S P Resende; Andreia Palmeira; Anake Kijjoa; Artur M S Silva; Maria Elizabeth Tiritan; Patrícia Pereira-Terra; Joana Freitas-Silva; Sandra Barreiro; Renata Silva; Fernando Remião; Eugénia Pinto; Paulo Martins da Costa; Emília Sousa; Madalena M M Pinto
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.